NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects

European Journal of Heart Failure

Volumn 9, Issue 6-7, 2007, Pages 660-666

  Schoen, S P ^a   Zimmermann, T ^a   Kittner, T ^a   Braun, M U ^a   Fuhrmann, J ^a   Schmeisser, A ^a   Strasser, R H ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atrial septal defect; NT proBNP; Percutaneous closure; Pulmonary hypertension; Right heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT RIGHT SHUNT; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LUNG PRESSURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

ADULT; ATRIAL FUNCTION, RIGHT; BLOOD PRESSURE; CARDIAC VOLUME; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; REFERENCE VALUES; STATISTICS; SYSTOLE; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 34247880308     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.01.014     Document Type: Article

References (34)

1. Kruger S., Graf J., Kunz D., et al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 40 (2002) 718-722
2. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
3. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
4. Koglin J., Pehlivanli S., Schwaiblmair M., et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol 38 (2001) 1934-1941
5. Burger M.R., and Burger A.J. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential. Curr Opin Investig Drugs 2 (2001) 929-935
6. Bolger A.P., Sharma R., Li W., et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 106 (2002) 92-99
7. Nagaya N., Nishikimi T., Okano Y., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
8. Nootens M., Kaufmann E., Rector T., et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 26 (1995) 1581-1585
9. Nagaya N., Nishikimi T., Uematsu M., et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102 (2000) 865-870
10. Moss AJ, Adams FH. Heart disease in infants, children, and adolescents including the fetus and young. 5th ed. Baltimore, Md: Williams & Wilkins; 1995:60-70, 689-701.
11. Graham Jr. T.P. Ventricular performance in congenital heart disease. Circulation 84 (1991) 2259-2274
12. Brochu M.C., Baril J.F., Dore A., Juneau M., De Guise P., and Mercier L.A. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 106 (2002) 1821-1826
13. Webb G. Do patients over 40 years of age benefit from closure of an atrial septal defect?. Heart 85 (2001) 249-250
14. Collinson P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. Analytical performance of the N-terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6 3 (2004) 365-368
15. Perloff J.K. Physical examination of the heart and circulation. 3rd ed. (2000), W.B. Saunders, Philadelphia
16. Drazner M.H., Rame J.E., Stevenson L.W., and Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
17. Yock P.G., and Popp R.L. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70 (1984) 657-662
18. Rominger M.B., Bachmann G.F., Pabst W., and Rau W.S. Right ventricular volumes and ejection fraction with fast cine MR imaging in breath-hold technique: applicability, normal values from 52 volunteers, and evaluation of 325 adult cardiac patients. J Magn Reson Imaging 10 (1999) 908-918
19. Alfakih K., Plein S., Thiele H., Jones T., Ridgway J.P., and Sivananthan M.U. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17 (2003) 323-329
20. Scharhag J., Schneider G., Urhausen A., Rochette V., Kramann B., and Kindermann W. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 40 (2002) 1856-1863
21. Thanopoulos B.D., Laskari C.V., Tsaousis G.S., Zarayelyan A., Vekiou A., and Papadopoulos G.S. Closure of atrial septal defects with the Amplatzer occlusion device: preliminary results. J Am Coll Cardiol 31 (1998) 1110-1116
22. Krumsdorf U., Keppeler P., Horvath K., Zadan E., Schrader R., and Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol 14 (2001) 49-55
23. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
24. Grantham J.A., and Burnett Jr. J.C. BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation 96 (1997) 388-390
25. Leuchte H.H., Holzapfel M., Baumgartner R.A., et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 43 (2004) 764-770
26. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 (2003) 2545-2547
27. Ishii J., Nomura M., Ito M., et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 301 (2000) 19-30
28. Bando M., Ishii Y., Sugiyama Y., and Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 93 (1999) 507-514
29. Salehian O., Horlick E., Schwerzmann M., et al. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol 45 4 (Feb 15 2005) 499-504
30. Giardini A., Donti A., Formigari R., et al. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol 43 10 (May 19 2004) 1886-1891
31. Muta H., Ishii M., Maeno Y., Akagi T., and Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 91 6 (2002) 649-652
32. Trojnarska O., Szyszka A., Gwizdala A., et al. Evaluation of exercise capacity with cardiopulmonary exercise testing and type b natriuretic peptide concentrations in adult patients with patent atrial septal defect. Cardiology 106 3 (Apr 21 2006) 154-160
33. Weber M., Dill T., Deetjen A., et al. Left ventricular adaptation after atrial septal defect closure assessed by increased concentrations of N-terminal pro-brain natriuretic peptide and cardiac magnetic resonance imaging in adult patients. Heart 92 5 (May 2006) 671-675
34. Nagaya N., Nishikimi T., Uematsu M., et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 136 2 (Aug 1998) 297-301